Clinical Trials Browser

Phase NA × Skin Neoplasms × pembrolizumab × Clear all

NCT07436390 2026-03-02

MAK

Phase NA Completed

Melanoma, Skin Neoplasms

NCT07422779 2026-02-20

MAK

Phase NA Recruiting

Melanoma, Skin Neoplasms

NCT05047094 2025-12-02

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

Phase NA Recruiting

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms